Avanos Medical, Inc.
AVNS
$12.43
$0.373.07%
NYSE
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 5.40% | -0.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.40% | -0.76% | |||
| Cost of Revenue | 5.29% | 1.84% | |||
| Gross Profit | 5.49% | -2.82% | |||
| SG&A Expenses | 37.54% | -7.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 316.67% | -128.57% | |||
| Total Operating Expenses | 10.98% | -3.81% | |||
| Operating Income | -46.67% | 41.03% | |||
| Income Before Tax | -4,526.32% | 53.23% | |||
| Income Tax Expenses | -752.78% | 89.47% | |||
| Earnings from Continuing Operations | -6,828.81% | 37.21% | |||
| Earnings from Discontinued Operations | 81.25% | 36.00% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9,339.53% | 138.89% | |||
| EBIT | -46.67% | 41.03% | |||
| EBITDA | -29.43% | 22.61% | |||
| EPS Basic | -9,337.43% | 138.52% | |||
| Normalized Basic EPS | -51.42% | 20.38% | |||
| EPS Diluted | -10,180.51% | 138.06% | |||
| Normalized Diluted EPS | -50.80% | 19.92% | |||
| Average Basic Shares Outstanding | 0.00% | 0.22% | |||
| Average Diluted Shares Outstanding | -1.29% | 0.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||